Depression Drugs … Big Pharma Expected to Lose $1.8 Billion by 2020

Seroquel (Quetiapine) 25 mg Tablet.

Image via Wikipedia

OWING TO THE GENERIC EROSION OF BLOCKBUSTER AGENTS, THE UNIPOLAR DEPRESSION DRUG MARKET WILL DECREASE FROM $11.6 BILLION IN 2010 TO $9.8 BILLION IN 2020

September 22, 2011-Burlington, Mass. … the unipolar depression drug market-which includes sales of products attributed to major depressive disorder, minor depression and dysthymia-will decrease …in the United States, France, Germany, Italy, Spain, United Kingdom and Japan. …

The findings also reveal that Bristol-Myers Squibb/Otsuka’s Abilify and AstraZeneca’s Seroquel continue to gain patient share as adjunctive major depressive disorder treatments, which will contribute to the stability of the unipolar depression market in the near term.

Retrieved 9/26/11. Read more: Owing to the generic erosion of blockbuster agents, the unipolar depression drug market will decrease in vallue

Advertisements
Leave a comment

What do you think?

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s